Govt Job: For M.Pharm in Research at Institute of Chemical Technology

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists.

The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs.

The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002.

Post : Project Fellow

Project Title :Development of exotic spice blends and related food products

Sponsor : M/s. Duval Enterprises Pvt Ltd

Project Investigator :Prof.K.S.Laddha

No. of Posts : One (01)

Project duration : 2 years

Eligibility : Master of Pharmacy

Fellowship : Rs.20,000/-p.m consolidated

The project fellow will be appointed initially for 6 months/one year and the tenure may be extended based on performance for the subsequent period. All appointments are terminated with end of the project.

Interested candidates should send their applications including cover letter, Curriculum vitae by email (research.assistant@staff.ictmumbai.edu.in)

The copy should also be forwarded to ks.laddha@ictmumbai.edu.in Please mention in the subject of email “Application for the post of Project Fellow Project Name Development of exotic spice blends and related food products”.

The applications should reach before 15 days from the advertisement date, along with cover letter, Curriculum vitae.

The interview will be held online after receiving and short listing of candidates. Selection will be based on an interview conducted by a committee.

The recommendation of the committee will be final. No TA/DA will be provided to appear for this interview.

Last Date : 4th February, 2022

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad